Aardvark Therapeutics Inc (AARD)

Finanzdaten der Aardvark Therapeutics Inc-Aktie (AARD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	32.85%15.08	22.46	18.70	17.70	15.85
Research and Development	36.89%10.46	16.57	14.30	13.74	13.15
Operating Income/Loss	32.85%-15.08	-22.46	-18.70	-17.70	-15.85
	20.43%0.70	0.88	1.11	1.39	1.48
Interest And Devidend Income	21.82%0.70	0.89	1.13	1.35	1.49
	33.36%-14.39	-21.59	-17.60	-16.32	-14.37
Attributable To Parent	33.36%-14.39	-21.59	-17.60	-16.32	-14.37
Basic Average Shares	0.14%21.85	21.82	-	21.71	21.69
Diluted Average Shares	0.14%21.85	21.82	-	21.71	21.69
Basic Earnings Per Share	33.33%-0.66	-0.99	-	-0.75	-0.66
Diluted Earnings Per Share	33.33%-0.66	-0.99	-	-0.75	-0.66